Distinct populations of highly potent TAU seed conformers in rapidly progressing Alzheimer’s disease

G. Jun, C. A. Ibrahim-Verbaas, M. Vronskaya, J.-C. Lambert, J. Chung, A. C. Naj, B. W. Kunkle, L.-S. Wang, J. C. Bis, C. Bellenguez, D. Harold, K. L. Lunetta, A. L. Destefano, B. Grenier-Boley, R. Sims, G. W. Beecham, A. V. Smith, V. Chouraki, K. L. Hamilton-Nelson, M. A. Ikram, N. Fievet, N. Denning, E. R. Martin, H. Schmidt, Y. Kamatani, M. L. Dunstan, O. Valladares, A. R. Laza, D. Zelenika, A. Ramirez, T. M. Foroud, S.-H. Choi, A. Boland, T. Becker, W. A. Kukull, S. J. van der Lee, F. Pasquier, C. Cruchaga, D. Beekly, A. L. Fitzpatrick, O. Hanon, M. Gill, R. Barber, V. Gudnason, D. Campion, S. Love, D. A. Bennett, N. Amin, C. Berr, M. Tsolaki, J. D. Buxbaum, O. L. Lopez, V. Deramecourt, N. C. Fox, L. B. Cantwell, L. Tárraga, C. Dufouil, J. Hardy, P. K. Crane, G. Eiriksdottir, D. Hannequin, R. Clarke, D. Evans, T. H. Mosley Jr., L. Letenneur, C. Brayne, W. Maier, P. De Jager, V. Emilsson, J.-F. Dartigues, H. Hampel, M. I. Kamboh, R. F. A. G. de Bruijn, C. Tzourio, P. Pastor, E. B. Larson, J. I. Rotter, M. C. O’Donovan, T. J. Montine, M. A. Nalls, S. Mead, E. M. Reiman, P. V. Jonsson, C. Holmes, P. H. S. George-Hyslop, M. Boada, P. Passmore, J. R. Wendland, R. Schmidt, K. Morgan, A. R. Winslow, J. F. Powell, M. Carasquillo, S. G. Younkin, J. Jakobsdóttir, J. S. K. Kauwe, K. C. Wilhelmsen, D. Rujescu, M. M. Nöthen, A. Hofman, L. Jones; IGAP Consortium, J. L. Haines, B. M. Psaty, C. Van Broeckhoven, P. Holmans, L. J. Launer, R. Mayeux, M. Lathrop, A. M. Goate, V. Escott-Price, S. Seshadri, M. A. Pericak-Vance, P. Amouyel, J. Williams, C. M. van Duijn, G. D. Schellenberg, L. A. Farrer, A novel Alzheimer disease locus located near the gene encoding TAU protein. Mol. Psychiatry 21, 108–117 (2016).

B. W. Kunkle, B. Grenier-Boley, R. Sims, J. C. Bis, V. Damotte, A. C. Naj, A. Boland, M. Vronskaya, S. J. van der Lee, A. Amlie-Wolf, C. Bellenguez, A. Frizatti, V. Chouraki, E. R. Martin, K. Sleegers, N. Badarinarayan, J. Jakobsdottir, K. L. Hamilton-Nelson, S. Moreno-Grau, R. Olaso, R. Raybould, Y. Chen, A. B. Kuzma, M. Hiltunen, T. Morgan, S. Ahmad, B. N. Vardarajan, J. Epelbaum, P. Hoffmann, M. Boada, G. W. Beecham, J.-G. Garnier, D. Harold, A. L. Fitzpatrick, O. Valladares, M.-L. Moutet, A. Gerrish, A. V. Smith, L. Qu, D. Bacq, N. Denning, X. Jian, Y. Zhao, M. D. Zompo, N. C. Fox, S.-H. Choi, I. Mateo, J. T. Hughes, H. H. Adams, J. Malamon, F. Sanchez-Garcia, Y. Patel, J. A. Brody, B. A. Dombroski, M. C. D. Naranjo, M. Daniilidou, G. Eiriksdottir, S. Mukherjee, D. Wallon, J. Uphill, T. Aspelund, L. B. Cantwell, F. Garzia, D. Galimberti, E. Hofer, M. Butkiewicz, B. Fin, E. Scarpini, C. Sarnowski, W. S. Bush, S. Meslage, J. Kornhuber, C. C. White, Y. Song, R. C. Barber, S. Engelborghs, S. Sordon, D. Voijnovic, P. M. Adams, R. Vandenberghe, M. Mayhaus, L. A. Cupples, M. S. Albert, P. P. De Deyn, W. Gu, J. J. Himali, D. Beekly, A. Squassina, A. M. Hartmann, A. Orellana, D. Blacker, E. Rodriguez-Rodriguez, S. Lovestone, M. E. Garcia, R. S. Doody, C. Munoz-Fernadez, R. Sussams, H. Lin, T. J. Fairchild, Y. A. Benito, C. Holmes, H. Karamujić-Čomić, M. P. Frosch, H. Thonberg, W. Maier, G. Roshchupkin, B. Ghetti, V. Giedraitis, A. Kawalia, S. Li, R. M. Huebinger, L. Kilander, S. Moebus, I. Hernández, M. I. Kamboh, R. M. Brundin, J. Turton, Q. Yang, M. J. Katz, L. Concari, J. Lord, A. S. Beiser, C. D. Keene, S. Helisalmi, I. Kloszewska, W. A. Kukull, A. M. Koivisto, A. Lynch, L. Tarraga, E. B. Larson, A. Haapasalo, B. Lawlor, T. H. Mosley, R. B. Lipton, V. Solfrizzi, M. Gill, W. T. Longstreth Jr., T. J. Montine, V. Frisardi, M. Diez-Fairen, F. Rivadeneira, R. C. Petersen, V. Deramecourt, I. Alvarez, F. Salani, A. Ciaramella, E. Boerwinkle, E. M. Reiman, N. Fievet, J. I. Rotter, J. S. Reisch, O. Hanon, C. Cupidi, A. G. A. Uitterlinden, D. R. Royall, C. Dufouil, R. G. Maletta, I. de Rojas, M. Sano, A. Brice, R. Cecchetti, P. S. George-Hyslop, K. Ritchie, M. Tsolaki, D. W. Tsuang, B. Dubois, D. Craig, C.-K. Wu, H. Soininen, D. Avramidou, R. L. Albin, L. Fratiglioni, A. Germanou, L. G. Apostolova, L. Keller, M. Koutroumani, S. E. Arnold, F. Panza, O. Gkatzima, S. Asthana, D. Hannequin, P. Whitehead, C. S. Atwood, P. Caffarra, H. Hampel, I. Quintela, Á. Carracedo, L. Lannfelt, D. C. Rubinsztein, L. L. Barnes, F. Pasquier, L. Frölich, S. Barral, B. M. Guinness, T. G. Beach, J. A. Johnston, J. T. Becker, P. Passmore, E. H. Bigio, J. M. Schott, T. D. Bird, J. D. Warren, B. F. Boeve, M. K. Lupton, J. D. Bowen, P. Proitsi, A. Boxer, J. F. Powell, J. R. Burke, J. S. K. Kauwe, J. M. Burns, M. Mancuso, J. D. Buxbaum, U. Bonuccelli, N. J. Cairns, A. M. Quillin, C. Cao, G. Livingston, C. S. Carlson, N. J. Bass, C. M. Carlsson, J. Hardy, R. M. Carney, J. Bras, M. M. Carrasquillo, R. Guerreiro, M. Allen, H. C. Chui, E. Fisher, C. Masullo, E. A. Crocco, C. De Carli, G. Bisceglio, M. Dick, L. Ma, R. Duara, N. R. Graff-Radford, D. A. Evans, A. Hodges, K. M. Faber, M. Scherer, K. B. Fallon, M. Riemenschneider, D. W. Fardo, R. Heun, M. R. Farlow, H. Kölsch, S. Ferris, M. Leber, T. M. Foroud, I. Heuser, D. R. Galasko, I. Giegling, M. Gearing, M. Hüll, D. H. Geschwind, J. R. Gilbert, J. Morris, R. C. Green, K. Mayo, J. H. Growdon, T. Feulner, R. L. Hamilton, L. E. Harrell, D. Drichel, L. S. Honig, T. D. Cushion, M. J. Huentelman, P. Hollingworth, C. M. Hulette, B. T. Hyman, R. Marshall, G. P. Jarvik, A. Meggy, E. Abner, G. E. Menzies, L.-W. Jin, G. Leonenko, L. M. Real, G. R. Jun, C. T. Baldwin, D. Grozeva, A. Karydas, G. Russo, J. A. Kaye, R. Kim, F. Jessen, N. W. Kowall, B. Vellas, J. H. Kramer, E. Vardy, F. M. La Ferla, K.-H. Jöckel, J. J. Lah, M. Dichgans, J. B. Leverenz, D. Mann, A. I. Levey, S. Pickering-Brown, A. P. Lieberman, N. Klopp, K. L. Lunetta, H.-E. Wichmann, C. G. Lyketsos, K. Morgan, D. C. Marson, K. Brown, F. Martiniuk, C. Medway, D. C. Mash, M. M. Nöthen, E. Masliah, N. M. Hooper, W. C. McCormick, A. Daniele, S. M. McCurry, A. Bayer, A. N. McDavid, J. Gallacher, A. C. McKee, H. van den Bussche, M. Mesulam, C. Brayne, B. L. Miller, S. Riedel-Heller, C. A. Miller, J. W. Miller, A. Al-Chalabi, J. C. Morris, C. E. Shaw, A. J. Myers, J. Wiltfang, S. O’Bryant, J. M. Olichney, V. Alvarez, J. E. Parisi, A. B. Singleton, H. L. Paulson, J. Collinge, W. R. Perry, S. Mead, E. Peskind, D. H. Cribbs, M. Rossor, A. Pierce, N. S. Ryan, W. W. Poon, B. Nacmias, H. Potter, S. Sorbi, J. F. Quinn, E. Sacchinelli, A. Raj, G. Spalletta, M. Raskind, C. Caltagirone, P. Bossù, M. D. Orfei, B. Reisberg, R. Clarke, C. Reitz, A. D. Smith, J. M. Ringman, D. Warden, E. D. Roberson, G. Wilcock, E. Rogaeva, A. C. Bruni, H. J. Rosen, M. Gallo, R. N. Rosenberg, Y. Ben-Shlomo, M. A. Sager, P. Mecocci, A. J. Saykin, P. Pastor, M. L. Cuccaro, J. M. Vance, J. A. Schneider, L. S. Schneider, S. Slifer, W. W. Seeley, A. G. Smith, J. A. Sonnen, S. Spina, R. A. Stern, R. H. Swerdlow, M. Tang, R. E. Tanzi, J. Q. Trojanowski, J. C. Troncoso, V. M. Van Deerlin, L. J. Van Eldik, H. V. Vinters, J. P. Vonsattel, S. Weintraub, K. A. Welsh-Bohmer, K. C. Wilhelmsen, J. Williamson, T. S. Wingo, R. L. Woltjer, C. B. Wright, C.-E. Yu, L. Yu, Y. Saba, A. Pilotto, M. J. Bullido, O. Peters, P. K. Crane, D. Bennett, P. Bosco, E. Coto, V. Boccardi, P. L. De Jager, A. Lleo, N. Warner, O. L. Lopez, M. Ingelsson, P. Deloukas, C. Cruchaga, C. Graff, R. Gwilliam, M. Fornage, A. M. Goate, P. Sanchez-Juan, P. G. Kehoe, N. Amin, N. Ertekin-Taner, C. Berr, S. Debette, S. Love, L. J. Launer, S. G. Younkin, J.-F. Dartigues, C. Corcoran, M. A. Ikram, D. W. Dickson, G. Nicolas, D. Campion, J. A. Tschanz, H. Schmidt, H. Hakonarson, J. Clarimon, R. Munger, R. Schmidt, L. A. Farrer, C. Van Broeckhoven, M. C. O’Donovan, A. L. De Stefano, L. Jones, J. L. Haines, J.-F. Deleuze, M. J. Owen, V. Gudnason, R. Mayeux, V. Escott-Price, B. M. Psaty, A. Ramirez, L.-S. Wang, A. Ruiz, C. M. van Duijn, P. A. Holmans, S. Seshadri, J. Williams, P. Amouyel, G. D. Schellenberg, J.-C. Lambert, M. A. Pericak-Vance; Alzheimer Disease Genetics Consortium (ADGC); European Alzheimer’s Disease Initiative (EADI); Cohorts for Heart and Aging Research in Genomic Epidemiology Consortium (CHARGE); Genetic and Environmental Risk in AD/Defining Genetic, Polygenic and Environmental Risk for Alzheimer’s Disease Consortium (GERAD/PERADES), Genetic meta-analysis of diagnosed Alzheimer's disease identifies new risk loci and implicates Aβ, TAU, immunity and lipid processing. Nat. Genet. 51, 414–430 (2019).

N. Chitravas, R. S. Jung, D. M. Kofskey, J. E. Blevins, P. Gambetti, R. J. Leigh, M. L. Cohen, Treatable neurological disorders misdiagnosed as Creutzfeldt-Jakob disease. Ann. Neurol. 70, 437–444 (2011).

C. Schmidt, M. Wolff, M. Weitz, T. Bartlau, C. Korth, I. Zerr, Rapidly progressive Alzheimer disease. Arch. Neurol. 68, 1124–1130 (2011).

C. Schmidt, K. Redyk, B. Meissner, L. Krack, N. von Ahsen, S. Roeber, H. Kretzschmar, I. Zerr, Clinical features of rapidly progressive Alzheimer's disease. Dement. Geriatr. Cogn. Disord. 29, 371–378 (2020).

C. Schmidt, S. Artjomova, M. Hoeschel, I. Zerr, CSF prion protein concentration and cognition in patients with Alzheimer disease. Prion 7, 229–234 (2013)

C. Schmidt, S. Haik, K. Satoh, A. Rabano, P. Martinez-Martin, S. Roeber, J. P. Brandel, M. Calero-Lara, J. de Pedro-Cuesta, J. L. Laplanche, J. J. Hauw, H. Kretzschmar, I. Zerr, Rapidly progressive Alzheimer's disease: A multicenter update. J. Alzheimers Dis. 30, 751–756 (2012).

J. A. Pillai, B. S. Appleby, J. Safar, J. B. Leverenz, Rapidly progressive Alzheimer's disease in two distinct autopsy cohorts. J. Alzheimers Dis. 64, 973–980 (2018).

M. L. Cohen, C. Kim, T. Haldiman, M. ElHag, P. Mehndiratta, T. Pichet, F. Lissemore, M. Shea, Y. Cohen, W. Chen, J. Blevins, B. S. Appleby, K. Surewicz, W. K. Surewicz, M. Sajatovic, C. Tatsuoka, S. Zhang, P. Mayo, M. Butkiewicz, J. L. Haines, A. J. Lerner, J. G. Safar, Rapidly progressive Alzheimer's disease features distinct structures of amyloid-β. Brain 138, 1009–1022 (2015).

W. Qiang, W. M. Yau, J. X. Lu, J. Collinge, R. Tycko, Structural variation in amyloid-β fibrils from Alzheimer's disease clinical subtypes. Nature 541, 217–221 (2017).

E. Drummond, S. Nayak, A. Faustin, G. Pires, R. A. Hickman, M. Askenazi, M. Cohen, T. Haldiman, C. Kim, X. Han, Y. Shao, J. G. Safar, B. Ueberheide, T. Wisniewski, Proteomic differences in amyloid plaques in rapidly progressive and sporadic Alzheimer's disease. Acta Neuropathol. 133, 933–954 (2017).

G. Gallardo, D. M. Holtzman, Amyloid-β and Tau at the crossroads of Alzheimer's disease. Adv. Exp. Med. Biol. 1184, 187 (2019).

H. Braak, K. Del Tredici, Evolutional aspects of Alzheimer's disease pathogenesis. J. Alzheimers Dis. 33 (Suppl. 1), S155–S161 (2013).

S. K. Kaufman, K. Del Tredici, T. L. Thomas, H. Braak, M. I. Diamond, Tau seeding activity begins in the transentorhinal/entorhinal regions and anticipates phospho-TAU pathology in Alzheimer's disease and PART. Acta Neuropathol. 136, 57–67 (2018).

D. W. Sanders, S. K. Kaufman, B. B. Holmes, M. I. Diamond, Prions and protein assemblies that convey biological information in health and disease. Neuron 89, 433–448 (2016).

B. Caughey, G. S. Baron, B. Chesebro, M. Jeffrey, Getting a grip on prions: Oligomers, amyloids, and pathological membrane interactions. Annu. Rev. Biochem. 78, 177–204 (2009).

N. J. Cobb, W. K. Surewicz, Prion diseases and their biochemical mechanisms. Biochemistry 48, 2574–2585 (2009).

R. Morales, K. Abid, C. Soto, The prion strain phenomenon: Molecular basis and unprecedented features. Biochim. Biophys. Acta 1772, 681–691 (2007).

S. B. Prusiner, in Principles of Molecular Medicine, J. L. Jameson, Ed. (Humana Press, 1998), pp. 927–939.

S. B. Prusiner, G. Legname, S. J. DeArmond, F. E. Cohen, J. Safar, D. Riesner, K. Kaneko, in Prion Biology and Diseases, S. B. Prusiner, Ed. (Cold Spring Harbor Laboratory Press, 2004), pp. 857–920.

M. A. Barria, A. Mukherjee, D. Gonzalez-Romero, R. Morales, C. Soto, De novo generation of infectious prions in vitro produces a new disease phenotype. PLOS Pathog. 5, e1000421 (2009).

J. Castilla, P. Saa, C. Hetz, C. Soto, In vitro generation of infectious scrapie prions. Cell 121, 195–206 (2005, 2005).

N. R. Deleault, B. T. Harris, J. R. Rees, S. Supattapone, Formation of native prions from minimal components in vitro. Proc. Natl. Acad. Sci. U.S.A. 104, 9741–9746 (2007).

J. C. Geoghegan, M. B. Miller, A. H. Kwak, B. T. Harris, S. Supattapone, Trans-dominant inhibition of prion propagation in vitro is not mediated by an accessory cofactor. PLOS Pathog. 5, e1000535 (2009).

J. I. Kim, I. Cali, K. Surewicz, Q. Kong, G. J. Raymond, R. Atarashi, B. Race, L. Qing, P. Gambetti, B. Caughey, W. K. Surewicz, Mammalian prions generated from bacterially expressed prion protein in the absence of any mammalian cofactors. J. Biol. Chem. 285, 14083–14087 (2010).

G. Legname, I. V. Baskakov, H.-O. B. Nguyen, D. Riesner, F. E. Cohen, S. J. DeArmond, S. B. Prusiner, Synthetic mammalian prions. Science 305, 673–676 (2004).

F. Wang, X. Wang, C. G. Yuan, J. Ma, Generating a prion with bacterially expressed recombinant prion protein. Science 327, 1132–1135 (2010).

C. Kim, X. Xiao, S. Chen, T. Haldiman, V. Smirnovas, D. Kofskey, M. Warren, K. Surewicz, N. R. Maurer, Q. Kong, W. Surewicz, J. G. Safar, Artificial strain of human prions created in vitro. Nat. Commun. 9, 2166 (2018).

R. B. Wickner, [URE3] as an altered URE2 protein: Evidence for a prion analog in Saccharomyces cerevisiae. Science 264, 566–569 (1994).

J. R. Glover, A. S. Kowal, E. C. Schirmer, M. M. Patino, J.-J. Liu, S. Lindquist, Self-seeded fibers formed by Sup35, the protein determinant of [PSI⁺], a heritable prion-like factor of S. cerevisiae. Cell 89, 811–819 (1997).

M. E. Kabir, J. G. Safar, Implications of prion adaptation and evolution paradigm for human neurodegenerative diseases. Prion 8, 111–116 (2014).

C. Kim, T. Haldiman, K. Surewicz, Y. Cohen, W. Chen, J. Blevins, M. S. Sy, M. Cohen, Q. Kong, G. C. Telling, W. K. Surewicz, J. G. Safar, Small protease sensitive oligomers of PrPSc in distinct human prions determine conversion rate of PrPC. PLOS Pathog. 8, e1002835 (2012).

C. Kim, T. Haldiman, Y. Cohen, W. Chen, J. Blevins, M. S. Sy, M. Cohen, J. G. Safar, Protease-sensitive conformers in broad spectrum of distinct PrPSc structures in sporadic Creutzfeldt-Jakob disease are indicator of progression rate. PLOS Pathog. 7, e1002242 (2011).

J. Safar, H. Wille, V. Itri, D. Groth, H. Serban, M. Torchia, F. E. Cohen, S. B. Prusiner, Eight prion strains have PrP^Sc molecules with different conformations. Nat. Med. 4, 1157–1165 (1998).

T. J. Montine, C. H. Phelps, T. G. Beach, E. H. Bigio, N. J. Cairns, D. W. Dickson, C. Duyckaerts, M. P. Frosch, E. Masliah, S. S. Mirra, P. T. Nelson, J. A. Schneider, D. R. Thal, J. Q. Trojanowski, H. V. Vinters, B. T. Hyman; National Institute on Aging; Alzheimer’s Association, National Institute on Aging-Alzheimer’s Association guidelines for the neuropathologic assessment of Alzheimer’s disease: A practical approach. Acta Neuropathol. 123, 1–11 (2012).

M. D. Geschwind, H. Shu, A. Haman, J. J. Sejvar, B. L. Miller, Rapidly progressive dementia. Ann. Neurol. 64, 97–108 (2008).

J. A. Pillai, A. Bonner-Jackson, L. M. Bekris, J. Safar, J. Bena, J. B. Leverenz, Highly elevated cerebrospinal fluid total Tau level reflects higher likelihood of non-amnestic subtype of Alzheimer’s disease. J. Alzheimers Dis. 70, 1051–1058 (2019).

C. Schmidt, A. Karch, S. Artjomova, M. Hoeschel, I. Zerr, Pre-progression rates in Alzheimer’s disease revisited. J. Alzheimers Dis. 35, 451–454 (2013).

C. Schmidt, M. Wolff, N. von Ahsen, I. Zerr, Alzheimer’s disease: Genetic polymorphisms and rate of decline. Dement. Geriatr. Cogn. Disord. 33, 84–89 (2012).

M. Cohen, B. Appleby, J. G. Safar, Distinct prion-like strains of amyloid beta implicated in phenotypic diversity of Alzheimer’s disease. Prion 10, 9–17 (2016).

N. Daude, C. Kim, S. G. Kang, G. Eskandari-Sedighi, T. Haldiman, J. Yang, S. C. Fleck, E. Gomez-Cardona, Z. Z. Han, S. Borrego-Ecija, S. Wohlgemuth, O. Julien, H. Wille, L. Molina-Porcel, E. Gelpi, J. G. Safar, D. Westaway, Diverse, evolving conformer populations drive distinct phenotypes in frontotemporal lobar degeneration caused by the same MAPT-P301L mutation. Acta Neuropathol. 139, 1045–1070 (2020).

J. G. Safar, X. Xiao, M. E. Kabir, S. Chen, C. Kim, T. Haldiman, Y. Cohen, W. Chen, M. L. Cohen, W. K. Surewicz, Structural determinants of phenotypic diversity and replication rate of human prions. PLOS Pathog. 11, e1004832 (2015).

T. Haldiman, C. Kim, Y. Cohen, W. Chen, J. Blevins, L. Qing, M. L. Cohen, J. Langeveld, G. C. Telling, Q. Kong, J. G. Safar, Co-existence of distinct prion types enables conformational evolution of human PrPSc by competitive selection. J. Biol. Chem. 288, 29846–29861 (2013).

R. Atarashi, R. A. Moore, V. L. Sim, A. G. Hughson, D. W. Dorward, H. A. Onwubiko, S. A. Priola, B. Caughey, Ultrasensitive detection of scrapie prion protein using seeded conversion of recombinant prion protein. Nat. Methods 4, 645–650 (2007).

G. Puoti, A. Bizzi, G. Forloni, J. G. Safar, F. Tagliavini, P. Gambetti, Sporadic human prion diseases: Molecular insights and diagnosis. Lancet Neurol. 11, 618–628 (2012).

J. G. Safar, in Prions and Diseases, W.-Q. Zou, P. Gambetti, Ed. (Springer Verlag, 2012), vol. 1.

J. G. Safar, Molecular pathogenesis of sporadic prion diseases in man. Prion 6, 108–115 (2012).

B. Minjarez, M. L. Valero Rustarazo, M. M. Sanchez del Pino, A. González-Robles, J. A. Sosa-Melgarejo, J. Luna-Muñoz, R. Mena, J. P. Luna-Arias, Identification of polypeptides in neurofibrillary tangles and total homogenates of brains with Alzheimer's disease by tandem mass spectrometry. J. Alzheimers Dis. 34, 239–262 (2013).

L. Buée, L. Troquier, S. Burnouf, K. Belarbi, A. Van der Jeugd, T. Ahmed, F. Fernandez-Gomez, R. Caillierez, M. E. Grosjean, S. Begard, B. Barbot, D. Demeyer, H. Obriot, I. Brion, V. Buée-Scherrer, C. A. Maurage, D. Balschun, R. D'Hooge, M. Hamdane, D. Blum, N. Sergeant, From TAU phosphorylation to TAU aggregation: What about neuronal death? Biochem. Soc. Trans. 38, 967–972 (2010).

W. H. Stoothoff, G. V. Johnson, Tau phosphorylation: Physiological and pathological consequences. Biochim. Biophys. Acta 1739, 280–297 (2005).

D. J. Irwin, T. J. Cohen, M. Grossman, S. E. Arnold, E. McCarty-Wood, V. M. Van Deerlin, V. M. Lee, J. Q. Trojanowski, Acetylated TAU neuropathology in sporadic and hereditary TAUopathies. Am. J. Pathol. 183, 344–351 (2013).

S. W. Min, X. Chen, T. E. Tracy, Y. Li, Y. Zhou, C. Wang, K. Shirakawa, S. S. Minami, E. Defensor, S. A. Mok, P. D. Sohn, B. Schilling, X. Cong, L. Ellerby, B. W. Gibson, J. Johnson, N. Krogan, M. Shamloo, J. Gestwicki, E. Masliah, E. Verdin, L. Gan, Critical role of acetylation in TAU-mediated neurodegeneration and cognitive deficits. Nat. Med. 21, 1154–1162 (2015).

S. Park, J. H. Lee, J. H. Jeon, M. J. Lee, Degradation or aggregation: The ramifications of post-translational modifications on TAU. BMB Rep. 51, 265–273 (2018).

G. G. Kovacs, Molecular pathology of neurodegenerative diseases: Principles and practice. J. Clin. Pathol. 72, 725–735 (2019).

C. E. Mays, J. van der Merwe, C. Kim, T. Haldiman, D. McKenzie, J. G. Safar, D. Westaway, Prion infectivity plateaus and conversion to symptomatic disease originate from falling precursor levels and increased levels of oligomeric PrPSc species. J. Virol. 89, 12418–12426 (2015).

S. Jeganathan, M. von Bergen, H. Brutlach, H. J. Steinhoff, E. Mandelkow, Global hairpin folding of TAU in solution. Biochemistry 45, 2283–2293 (2006).

Q. Li, F. Wang, X. Xiao, C. Kim, J. Bohon, J. Kiselar, J. G. Safar, J. Ma, W. K. Surewicz, Structural attributes of mammalian prion infectivity: Insights from studies with synthetic prions. J. Biol. Chem. 293, 18494–18503 (2018).

B. R. Groveman, C. D. Orru, A. G. Hughson, L. D. Raymond, G. Zanusso, B. Ghetti, K. J. Campbell, J. Safar, D. Galasko, B. Caughey, Rapid and ultra-sensitive quantitation of disease-associated α-synuclein seeds in brain and cerebrospinal fluid by αSyn RT-QuIC. Acta Neuropathol. Commun. 6, 7 (2018).

A. Foutz, B. S. Appleby, C. Hamlin, X. Liu, S. Yang, Y. Cohen, W. Chen, J. Blevins, C. Fausett, H. Wang, P. Gambetti, S. Zhang, A. Hughson, C. Tatsuoka, L. B. Schonberger, M. L. Cohen, B. Caughey, J. G. Safar, Diagnostic and prognostic value of human prion detection in cerebrospinal fluid. Ann. Neurol. 81, 79–92 (2017).

S. Jeganathan, M. von Bergen, E. M. Mandelkow, E. Mandelkow, The natively unfolded character of TAU and its aggregation to Alzheimer-like paired helical filaments. Biochemistry 47, 10526–10539 (2008).

V. Daebel, S. Chinnathambi, J. Biernat, M. Schwalbe, B. Habenstein, A. Loquet, E. Akoury, K. Tepper, H. Muller, M. Baldus, C. Griesinger, M. Zweckstetter, E. Mandelkow, V. Vijayan, A. Lange, β-Sheet core of tau paired helical filaments revealed by solid-state NMR. J. Am. Chem. Soc. 134, 13982 (2012).

S. Taniguchi-Watanabe, T. Arai, F. Kametani, T. Nonaka, M. Masuda-Suzukake, A. Tarutani, S. Murayama, Y. Saito, K. Arima, M. Yoshida, H. Akiyama, A. Robinson, D. M. A. Mann, T. Iwatsubo, M. Hasegawa, Biochemical classification of TAUopathies by immunoblot, protein sequence and mass spectrometric analyses of sarkosyl-insoluble and trypsin-resistant TAU. Acta Neuropathol. 131, 267–280 (2016).

C. D. Orru, J. M. Wilham, S. Vascellari, A. G. Hughson, B. Caughey, New generation QuIC assays for prion seeding activity. Prion 6, 147–152 (2012).

A. M. Oelschlegel, C. Weissmann, Acquisition of drug resistance and dependence by prions. PLOS Pathog. 9, e1003158 (2013).

J. Li, S. Browning, S. P. Mahal, A. M. Oelschlegel, C. Weissmann, Darwinian evolution of prions in cell culture. Science 327, 869–872 (2010).

S. Safarian, M. Alimohammadi, A. A. Saberi, A. A. Moosavi-Movahedi, A statistical mechanical deconvolution of the differential scanning calorimetric profiles of the thermal denaturation of cyanomethemoglobin. Protein J. 24, 175–181 (2005).

A. I. Azuaga, C. M. Dobson, P. L. Mateo, F. Conejero-Lara, Unfolding and aggregation during the thermal denaturation of streptokinase. Eur. J. Biochem. 269, 4121–4133 (2002).

C. L. Masters, D. J. Selkoe, Biochemistry of amyloid β-protein and amyloid deposits in Alzheimer disease. Cold Spring Harb. Perspect. Med. 2, a006262 (2012).

H. Mirbaha, D. Chen, O. A. Morazova, K. M. Ruff, A. M. Sharma, X. Liu, M. Goodarzi, R. V. Pappu, D. W. Colby, H. Mirzaei, L. A. Joachimiak, M. I. Diamond, Inert and seed-competent TAU monomers suggest structural origins of aggregation. eLife 7, e36584 (2018).

A. M. Sharma, T. L. Thomas, D. R. Woodard, O. M. Kashmer, M. I. Diamond, Tau monomer encodes strains. eLife 7, e37813 (2018).

J. Cummings, G. Lee, A. Ritter, M. Sabbagh, K. Zhong, Alzheimer’s disease drug development pipeline: 2019. Alzheimers Dement. 5, 272–293 (2019).

W. Zhang, B. Falcon, A. G. Murzin, J. Fan, R. A. Crowther, M. Goedert, S. H. W. Scheres, Heparin-induced tau filaments are polymorphic and differ from those in Alzheimer’s and Pick’s diseases. eLife 8, e43584 (2019).

B. Falcon, J. Zivanov, W. Zhang, A. G. Murzin, H. J. Garringer, R. Vidal, R. A. Crowther, K. L. Newell, B. Ghetti, M. Goedert, S. H. W. Scheres, Novel tau filament fold in chronic traumatic encephalopathy encloses hydrophobic molecules. Nature 568, 420–423 (2019).

M. Goedert, Tau filaments in neurodegenerative diseases. FEBS Lett. 592, 2383–2391 (2018).

B. Falcon, W. Zhang, M. Schweighauser, A. G. Murzin, R. Vidal, H. J. Garringer, B. Ghetti, S. H. W. Scheres, M. Goedert, Tau filaments from multiple cases of sporadic and inherited Alzheimer’s disease adopt a common fold. Acta Neuropathol. 136, 699–708 (2018).

H. Wesseling, W. Mair, M. Kumar, C. N. Schlaffner, S. Tang, P. Beerepoot, B. Fatou, A. J. Guise, L. Cheng, S. Takeda, J. Muntel, M. S. Rotunno, S. Dujardin, P. Davies, K. S. Kosik, B. L. Miller, S. Berretta, J. C. Hedreen, L. T. Grinberg, W. W. Seeley, B. T. Hyman, H. Steen, J. A. Steen, Tau PTM profiles identify patient heterogeneity and stages of Alzheimer’s disease. Cell 183, 1699–1713.e13 (2020).

S. Dujardin, C. Commins, A. Lathuiliere, P. Beerepoot, A. R. Fernandes, T. V. Kamath, M. B. De Los Santos, N. Klickstein, D. L. Corjuc, B. T. Corjuc, P. M. Dooley, A. Viode, D. H. Oakley, B. D. Moore, K. Mullin, D. Jean-Gilles, R. Clark, K. Atchison, R. Moore, L. B. Chibnik, R. E. Tanzi, M. P. Frosch, A. Serrano-Pozo, F. Elwood, J. A. Steen, M. E. Kennedy, B. T. Hyman, Tau molecular diversity contributes to clinical heterogeneity in Alzheimer’s disease. Nat. Med. 26, 1256–1263 (2020).

D. Sepulveda-Falla, L. Chavez-Gutierrez, E. Portelius, J. I. Vélez, S. Dujardin, A. Barrera-Ocampo, F. Dinkel, C. Hagel, B. Puig, C. Mastronardi, F. Lopera, B. T. Hyman, K. Blennow, M. Arcos-Burgos, B. de Strooper, M. Glatzel, A multifactorial model of pathology for age of onset heterogeneity in familial Alzheimer’s disease. Acta Neuropathol. 141, 217–233 (2021).

M. K. Siddiqi, C. Kim, T. Haldiman, M. Kacirova, B. Wang, J. Bohon, M. R. Chance, J. Kiselar, J. G. Safar, Structurally distinct external solvent-exposed domains drive replication of major human prions. PLOS Pathog. 17, e1009642 (2021).

G. Legname, H.-O. B. Nguyen, D. Peretz, F. E. Cohen, S. J. DeArmond, S. B. Prusiner, Continuum of prion protein structures enciphers a multitude of prion isolate-specified phenotypes. Proc. Natl. Acad. Sci. U.S.A. 103, 19105–19110 (2006).

M. Tanaka, S. R. Collins, B. H. Toyama, J. S. Weissman, The physical basis of how prion conformations determine strain phenotypes. Nature 442, 585–589 (2006).

A. K. Paravastu, R. D. Leapman, W. M. Yau, R. Tycko, Molecular structural basis for polymorphism in Alzheimer’s beta-amyloid fibrils. Proc. Natl. Acad. Sci. U.S.A. 105, 18349–18354 (2008).

T. C. T. Michaels, A. Šarić, J. Habchi, S. Chia, G. Meisl, M. Vendruscolo, C. M. Dobson, T. P. J. Knowles, Chemical kinetics for bridging molecular mechanisms and macroscopic measurements of amyloid fibril formation. Annu. Rev. Phys. Chem. 69, 273–298 (2018).

G. P. Noble, D. W. Wang, D. J. Walsh, J. R. Barone, M. B. Miller, K. A. Nishina, S. Li, S. Supattapone, A structural and functional comparison between infectious and non-Infectious autocatalytic recombinant PrP conformers. PLOS Pathog. 11, e1005017 (2015).

N. R. Deleault, D. J. Walsh, J. R. Piro, F. Wang, X. Wang, J. Ma, J. R. Rees, S. Supattapone, Cofactor molecules maintain infectious conformation and restrict strain properties in purified prions. Proc. Natl. Acad. Sci. U.S.A. 109, E1938–E1946 (2012).

N. R. Deleault, J. R. Piro, D. J. Walsh, F. Wang, J. Ma, J. C. Geoghegan, S. Supattapone, Isolation of phosphatidylethanolamine as a solitary cofactor for prion formation in the absence of nucleic acids. Proc. Natl. Acad. Sci. U.S.A. 109, 8546–8551 (2012).

A. Aoyagi, C. Condello, J. Stöhr, W. Yue, B. M. Rivera, J. C. Lee, A. L. Woerman, G. Halliday, S. van Duinen, M. Ingelsson, L. Lannfelt, C. Graff, T. D. Bird, C. D. Keene, W. W. Seeley, W. F. DeGrado, S. B. Prusiner, Aβ and tau prion-like activities decline with longevity in the Alzheimer’s disease human brain. Sci. Transl. Med. 11, eaat8462 (2019).

S. G. Kang, Z. Z. Han, N. Daude, E. McNamara, S. Wohlgemuth, L. Molina-Porcel, J. G. Safar, S. A. Mok, D. Westaway, Pathologic tau conformer ensembles induce dynamic, liquid-liquid phase separation events at the nuclear envelope. BMC Biol. 19, 199 (2021).

C. Tatsuoka, H. Tseng, J. Jaeger, F. Varadi, M. A. Smith, T. Yamada, K. A. Smyth, A. J. Lerner; The Alzheimer’s Disease Neuroimaging Initiative, Modeling the heterogeneity in risk of progression to Alzheimer’s disease across cognitive profiles in mild cognitive impairment. Alzheimers Res. Ther. 5, 14 (2013).

D. T. Chien, A. K. Szardenings, S. Bahri, J. C. Walsh, F. Mu, C. Xia, W. R. Shankle, A. J. Lerner, M. Y. Su, A. Elizarov, H. C. Kolb, Early clinical PET imaging results with the novel PHF-tau radioligand [F18]-T808. J. Alzheimers Dis. 38, 171–184 (2014).

G. M. McKhann, D. S. Knopman, H. Chertkow, B. T. Hyman, C. R. Jack Jr., C. H. Kawas, W. E. Klunk, W. J. Koroshetz, J. J. Manly, R. Mayeux, R. C. Mohs, J. C. Morris, M. N. Rossor, P. Scheltens, M. C. Carrillo, B. Thies, S. Weintraub, C. H. Phelps, The diagnosis of dementia due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimers Dement. 7, 263–269 (2011).

B. T. Hyman, C. H. Phelps, T. G. Beach, E. H. Bigio, N. J. Cairns, M. C. Carrillo, D. W. Dickson, C. Duyckaerts, M. P. Frosch, E. Masliah, S. S. Mirra, P. T. Nelson, J. A. Schneider, D. R. Thal, B. Thies, J. Q. Trojanowski, H. V. Vinters, T. J. Montine, National Institute on Aging-Alzheimer’s Association guidelines for the neuropathologic assessment of Alzheimer’s disease. Alzheimers Dement. 8, 1–13 (2012).

D. L. Beekly, E. M. Ramos, W. W. Lee, W. D. Deitrich, M. E. Jacka, J. Wu, J. L. Hubbard, T. D. Koepsell, J. C. Morris, W. A. Kukull; NIA Alzheimer's Disease Centers, The National Alzheimer's Coordinating Center (NACC) database: The Uniform Data Set. Alzheimer Dis. Assoc. Disord. 21, 249–258 (2007).

P. Parchi, W. Zou, W. Wang, P. Brown, S. Capellari, B. Ghetti, N. Kopp, W. J. Schulz-Schaeffer, H. A. Kretzschmar, M. W. Head, J. W. Ironside, P. Gambetti, S. G. Chen, Genetic influence on the structural variations of the abnormal prion protein. Proc. Natl. Acad. Sci. U.S.A. 97, 10168–10172 (2000).

J. G. Safar, M. D. Geschwind, C. Deering, S. Didorenko, M. Sattavat, H. Sanchez, A. Serban, M. Vey, H. Baron, K. Giles, B. L. Miller, S. J. DeArmond, S. B. Prusiner, Diagnosis of human prion disease. Proc. Natl. Acad. Sci. U.S.A. 102, 3501–3501 (2005).

F. Sanger, S. Nicklen, A. R. Coulson, DNA sequencing with chain-terminating inhibitors. Proc. Natl. Acad. Sci. U.S.A. 74, 5463–5467 (1977).

K. Rascovsky, J. R. Hodges, D. Knopman, M. F. Mendez, J. H. Kramer, J. Neuhaus, J. C. van Swieten, H. Seelaar, E. G. Dopper, C. U. Onyike, A. E. Hillis, K. A. Josephs, B. F. Boeve, A. Kertesz, W. W. Seeley, K. P. Rankin, J. K. Johnson, M. L. Gorno-Tempini, H. Rosen, C. E. Prioleau-Latham, A. Lee, C. M. Kipps, P. Lillo, O. Piguet, J. D. Rohrer, M. N. Rossor, J. D. Warren, N. C. Fox, D. Galasko, D. P. Salmon, S. E. Black, M. Mesulam, S. Weintraub, B. C. Dickerson, J. Diehl-Schmid, F. Pasquier, V. Deramecourt, F. Lebert, Y. Pijnenburg, T. W. Chow, F. Manes, J. Grafman, S. F. Cappa, M. Freedman, M. Grossman, B. L. Miller, Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia. Brain 134, 2456–2477 (2011).

J. Safar, S. B. Prusiner, Chapter 29 Molecular studies of prion diseases. Prog. Brain Res. 117, 421–434 (1998).

R. de Silva, T. Lashley, G. Gibb, D. Hanger, A. Hope, A. Reid, R. Bandopadhyay, M. Utton, C. Strand, T. Jowett, N. Khan, B. Anderton, N. Wood, J. Holton, T. Revesz, A. Lees, Pathological inclusion bodies in TAUopathies contain distinct complements of TAU with three or four microtubule-binding repeat domains as demonstrated by new specific monoclonal antibodies. Neuropathol. Appl. Neurobiol. 29, 288–302 (2003).

K. C. Luk, C. Song, P. O’Brien, A. Stieber, J. R. Branch, K. R. Brunden, J. Q. Trojanowski, V. M. Lee, Exogenous alpha-synuclein fibrils seed the formation of Lewy body-like intracellular inclusions in cultured cells. Proc. Natl. Acad. Sci. U.S.A. 106, 20051–20056 (2009).

J. G. Safar, S. J. DeArmond, K. Kociuba, C. Deering, S. Didorenko, E. Bouzamondo-Bernstein, S. B. Prusiner, P. Tremblay, Prion clearance in bigenic mice. J. Gen. Virol. 86, 2913–2923 (2005).

J. G. Safar, K. Kellings, A. Serban, D. Groth, J. E. Cleaver, S. B. Prusiner, D. Riesner, Search for a prion-specific nucleic acid. J. Virol. 79, 10796–10806 (2005).

P. D. Dinkel, A. Siddiqua, H. Huynh, M. Shah, M. Margittai, Variations in filament conformation dictate seeding barrier between three- and four-repeat TAU. Biochemistry 50, 4330–4336 (2011).

I. S. Lee, J. R. Long, S. B. Prusiner, J. G. Safar, Selective precipitation of prions by polyoxometalate complexes. J. Am. Chem. Soc. 127, 13802–13803 (2005).

J. G. Safar, H. Wille, M. D. Geschwind, C. Deering, D. Latawiec, A. Serban, D. J. King, G. Legname, K. H. Weisgraber, R. W. Mahley, B. L. Miller, S. J. DeArmond, S. B. Prusiner, Human prions and plasma lipoproteins. Proc. Natl. Acad. Sci. U.S.A. 103, 11312–11317 (2006).

J. G. Safar, M. Scott, J. Monaghan, C. Deering, S. Didorenko, J. Vergara, H. Ball, G. Legname, E. Leclerc, L. Solforosi, H. Serban, D. Groth, D. R. Burton, S. B. Prusiner, R. A. Williamson, Measuring prions causing bovine spongiform encephalopathy or chronic wasting disease by immunoassays and transgenic mice. Nat. Biotechnol. 20, 1147–1150 (2002).

C. E. Mays, C. Kim, T. Haldiman, J. van der Merwe, A. Lau, J. Yang, J. Grams, M. A. Di Bari, R. Nonno, G. C. Telling, Q. Kong, J. Langeveld, D. McKenzie, D. Westaway, J. G. Safar, Prion disease tempo determined by host-dependent substrate reduction. J. Clin. Invest. 124, 847–858 (2014).

S. B. Prusiner, W. J. Hadlow, C. M. Eklund, R. E. Race, S. P. Cochran, Sedimentation characteristics of the scrapie agent from murine spleen and brain. Biochemistry 17, 4987–4992 (1978).

J. Steensgaard, S. Humphries, S. P. Spragg, in Preparative Centrifugation: A Practical Approach, D. Rickwood, Ed. (IRL Press, 1992), pp. 187–232.

H. Wille, S. B. Prusiner, Ultrastructural studies on scrapie prion protein crystals obtained from reverse micellar solutions. Biophys. J. 76, 1048–1062 (1999).

B. G. Fox, P. G. Blommel, Autoinduction of protein expression. Curr. Protoc. Protein Sci. Chapter 5, Unit 5.23 (2009).

A. Kraus, E. Saijo, M. A. Metrick II, K. Newell, C. J. Sigurdson, G. Zanusso, B. Ghetti, B. Caughey, Seeding selectivity and ultrasensitive detection of tau aggregate conformers of Alzheimer disease. Acta Neuropathol. 137, 585–598 (2019).

D. W. Sanders, S. K. Kaufman, S. L. DeVos, A. M. Sharma, H. Mirbaha, A. Li, S. J. Barker, A. C. Foley, J. R. Thorpe, L. C. Serpell, T. M. Miller, L. T. Grinberg, W. W. Seeley, M. I. Diamond, Distinct tau prion strains propagate in cells and mice and define different tauopathies. Neuron 82, 1271–1288 (2014).

J. Collinge, A. R. Clarke, A general model of prion strains and their pathogenicity. Science 318, 930–936 (2007).